PCN7 THE LIFETIME COST OF GEFITINIB ('IRESSA') IN TREATING PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC)
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65741-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65741-5/fulltext
Title :
PCN7 THE LIFETIME COST OF GEFITINIB ('IRESSA') IN TREATING PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65741-5&doi=10.1016/S1098-3015(10)65741-5
First page :
Section Title :
Open access? :
No
Section Order :
110